1. About.com
  2. Health
  3. Headaches & Migraines
OxyContin® Updates

The recent controversy surrounding OxyContin® has been and continues to be an important concern to headache and migraine sufferers. This page will be used to post updated information as it becomes available.
  • August 22, 2002
    • West Virginia Judge Dismisses OxyContin® Case Against Purdue Pharma
      Court rules: Purdue’s warnings “clearly laid out “ risk of misuse; plaintiff’s illegal use of OxyContin® bars recovery.
    • Full Story
  • August 5, 2002
    • Legal Victories for Purdue Pharma Mount in OxyContin® Litigation
      Ohio and Kentucky Cases Bring Dismissal Total to 13
    • Full Story
  • June 27, 2002
    • Purdue Pharma Initiates National Surveillance System to Track Diversion and Abuse of Controlled Pain Medications
    • Full Story
  • June 26, 2002
    • Another Legal Victory for Purdue Pharma in OxyContin® Litigation
      Louisiana Plaintiff Withdraws Lawsuit
    • Full Story
  • June 25, 2002
    • Purdue Pharma Dedicates State-of-the-Art Research Center in New Jersey’s “Pharma Corridor”
    • Full Story
  • June 18, 2002
    • Purdue Pharma Provides Update on Development of New Abuse-Resistant Pain Medications
    • Full Story
  • May 28, 2002
    • Purdue Pharma Engages Giuliani Partners As External Advisor
      Issues To Be Addressed Include Combating Abuse and Diversion Of Prescription Drugs and Systems Security
    • Full Story
  • April 24, 2002
    • Four More Purdue Pharma Victories in OxyContin Litigation
    • Full Story
  • April 16, 2002
    • Purdue Pharma Disputes DEA Analysis of Medical Examiner Reports
    • Full Story
  • March 28, 2002
    • Targeting Abuse Might Also Help Medicaid Program
      The state of Kentucky may seek federal funding for a high-tech system for tracking frequently abused prescription drugs, saving their Medicaid program millions of dollars.
    • Full Story
  • February 28, 2002
    • Class Action Denied in Kentucky OxyContin Litigation; Judge Rules That Plaintiffs Failed All Legal Tests
    • Full Story
  • February 6, 2002
    • Purdue Pharma Announces $50,000 Prize for Pain Research
    • Full Story
  • February 5, 2002
    • Purdue Pharma Launches the Purdue Pharma Fund to Focus Contributions on Pain Management
    • Initial $3 Million Grant to Massachusetts General Hospital Will Make Possible
      Expanded, State-of-the-Art Pain Education, Treatment, and Research Center
    • Full Story
  • February 4, 2002
    • OxyContin Lawsuit Dismissed in Mississippi; Federal Court in Kentucky refuses Plaintiffs' Motion to Send Case Back to State Court.
    • Third Voluntary Dismissal of OxyContin Litigation in Six Weeks; No Liability in Kentucky for Pharmaceutical Sales Rep Merely Distributing OxyContin
    • Full Story
  • February, 2002
    • Legislators in Kentucky are considering a bill that would give police access to confidential prescription records, as part of a campaign to eradicate abuse of the pain-killer OxyContin.
    • Full Story at About Substance Abuse
  • January 2, 2002
    • Federal Judge in Kentucky Rejects Injunction on OxyContin: Ruling protects patient access to appropriate pain medications.
    • Full Story
  • December 3, 2001
    • Purdue Pharma Begins Clinical Studies of Abuse-Resistant Pain Medication Medications.
    • Full Story
  • November 12, 2001
    • "Painfully Obvious™" Campaign Warns Kids About The Dangers Of Abusing Prescription Medications.
    • Full Story
  • October 23, 2001
    • Drug Enforcement Agency, 21 Health Groups Call for Balanced Policy on Prescription Pain Medications like OxyContin. Goal Is to Protect Legitimate Use of Prescription Drugs for Patients in Pain.
    • Full Story
  • August 22, 2001
    Jenette Restivo, former About editor, interviews Michael John Coleman of MAGNUM about the needs of chronic pain patients and the OxyContin abuse issue. ABC News Article
  • August 21, 2001
    Purdue Responds to Letter from Pennsylvania Attorney General Mike Fisher
  • August 8, 2001
    • International Patent Application To Be Published on Abuse-Resistant
      Pain Reliever Being Developed by Purdue Pharma
    • Full Story
  • July 25, 2001
    Purdue Pharma Restates Physician Prescribing Information for OxyContin® Tablets
  • May 4, 2001
    Purdue Pharma Statement on DEA Program to Reduce Diversion of OxyContin® Tablets
  • May 10, 2001
    Statement Regarding Suspension of 160 mg OxyContin® Tablets

 

 


Chat Status:




  1. About.com
  2. Health
  3. Headaches & Migraines

©2012 About.com. All rights reserved. 

A part of The New York Times Company.

We comply with the HONcode standard
for trustworthy health
information: verify here.